anmelden
SLI
2.143,87
PKT
+4,47
PKT
+0,21
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.06.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.06.18 | UBS overweight | JP Morgan Chase & Co. | |
| 04.06.18 | Roche overweight | JP Morgan Chase & Co. | |
| 01.06.18 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 01.06.18 | Givaudan Neutral | BNP PARIBAS | |
| 31.05.18 | Givaudan overweight | JP Morgan Chase & Co. | |
| 31.05.18 | Roche Reduce | HSBC | |
| 31.05.18 | Novartis Hold | HSBC | |
| 31.05.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 30.05.18 | Nestlé Neutral | UBS AG | |
| 30.05.18 | UBS Outperform | Credit Suisse Group | |
| 30.05.18 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 30.05.18 | Roche Hold | Deutsche Bank AG | |
| 29.05.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 29.05.18 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.05.18 | Roche overweight | JP Morgan Chase & Co. | |
| 29.05.18 | Swiss Re Sell | UBS AG | |
| 29.05.18 | Roche buy | Baader Bank | |
| 29.05.18 | Roche buy | Jefferies & Company Inc. | |
| 29.05.18 | Novartis Hold | HSBC | |
| 28.05.18 | Swiss Re buy | Baader Bank | |
| 25.05.18 | Novartis Neutral | Credit Suisse Group | |
| 25.05.18 | Zurich Insurance Hold | Deutsche Bank AG | |
| 25.05.18 | Swiss Re buy | Deutsche Bank AG | |
| 25.05.18 | Swiss Re overweight | Barclays Capital | |
| 25.05.18 | Roche Underperform | Credit Suisse Group | |
| 23.05.18 | Givaudan buy | Baader Bank | |
| 23.05.18 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.05.18 | Roche overweight | Barclays Capital | |
| 23.05.18 | Holcim Neutral | JP Morgan Chase & Co. | |
| 22.05.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 22.05.18 | Roche Hold | Deutsche Bank AG | |
| 22.05.18 | Roche buy | Jefferies & Company Inc. | |
| 22.05.18 | UBS Neutral | Goldman Sachs Group Inc. | |
| 22.05.18 | Novartis Underweight | Barclays Capital | |
| 22.05.18 | Roche Neutral | Citigroup Corp. | |
| 22.05.18 | UBS overweight | JP Morgan Chase & Co. | |
| 22.05.18 | Roche overweight | JP Morgan Chase & Co. | |
| 22.05.18 | UBS overweight | JP Morgan Chase & Co. | |
| 22.05.18 | UBS buy | Goldman Sachs Group Inc. |